Home LiteratureArticle Details
PMID: 7540887 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.

Blood ·Vol. 86 ·No. 1 ·1995-07-01 ·Pages 381-9

Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagannath S, Condino J, Lee B, Barlogie B, Tricot G

Abstract

High-dose therapy with autologous marrow or peripheral blood stem cell (PBSC) rescue has been extensively applied in the treatment of multiple myeloma (MM) patients during the past 10 years resulting in improved event-free and overall survival when compared with standard chemotherapy. However, relapses are common and cure is unlikely in the majority of patients. Because both bone marrow and PBSCs are contaminated with myeloma cells it is conceivable that relapse after autotransplantation originates at least in part from autografted tumor cells. In this study, mobilized PBSCs were examined for the presence of myeloma cells based on immunophenotyping and sensitive polymerase chain reaction (PCR)-based techniques. In addition, CD34+ Lin- Thy+ stem cells were purified from mobilized PBSC harvests of 10 MM patients by sequentially using counterflow elutriation centrifugation, treatment with phenylalanine methylester, and flow sorting, using 5-parameter gating (propidium iodide, forward scatter, side scatter, CD34+ v Lin- and CD34+ v Thy+). Virtually all mobilized unsorted PBSC preparations contained myeloma cells in sufficient quantities (range, < 0.01 to > 10%) potentially causing a disease relapse. Stem cell purification led to an overall enrichment by about 50-fold in all 10 patients; approximately 90% of the final cell population expressed CD34+ Lin- Thy+ with no evidence of myeloma cell contamination based on flow cytometric analysis of CD38bright cells (< 0.1%). Quantitative PCR amplification of patient-specific complementarity determining region III (CDRIII) DNA sequences showed depletion of clonal B cells by 2.7 to 7.3 logs, with the highest log reduction noted in the samples initially containing the most tumor cells. Our results show that purification of CD34+ Lin- Thy+ cells depletes myeloma cells to undetectable levels from up to 10% present in unsorted PBSCs, thus offering a tool to investigate whether MM relapse after autotransplantation can be reduced markedly.

MeSH Terms
ADP-ribosyl Cyclase ADP-ribosyl Cyclase 1 Antigens, CD/analysis Antigens, CD34 Antigens, Differentiation/analysis Antigens, Differentiation, T-Lymphocyte/analysis Blood Component Removal CD56 Antigen Cell Separation/methods Centrifugation Consensus Sequence Countercurrent Distribution Cyclophosphamide/pharmacology DNA Primers Feasibility Studies Flow Cytometry Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology Hematopoietic Stem Cell Transplantation/methods Hematopoietic Stem Cells/chemistry,drug effects Humans Immunoglobulin Heavy Chains/genetics Immunophenotyping Membrane Glycoproteins Multiple Myeloma/pathology N-Glycosyl Hydrolases/analysis Neoplastic Stem Cells/chemistry Phenylalanine/analogs & derivatives,pharmacology Plasma Cells/chemistry Polymerase Chain Reaction Thy-1 Antigens/analysis
Chemicals
Antigens, CD Antigens, CD34 Antigens, Differentiation Antigens, Differentiation, T-Lymphocyte CD56 Antigen DNA Primers Immunoglobulin Heavy Chains Membrane Glycoproteins Thy-1 Antigens phenylalanine methyl ester Phenylalanine Granulocyte-Macrophage Colony-Stimulating Factor Cyclophosphamide N-Glycosyl Hydrolases ADP-ribosyl Cyclase CD38 protein, human ADP-ribosyl Cyclase 1
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Gazitt Y
Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, CA 72205, USA.
Reading C C
Hoffman R
Wickrema A
Vesole D H
Jagannath S
Condino J
Lee B
Barlogie B
Tricot G
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
1995-07-01
Pages
381-9
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NCI NIH HHS · CA 539340 · United States
NCI NIH HHS · CA 55164 · United States
NCI NIH HHS · P01-CA 55819 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com